Compositions and methods for treating cancer using IGSF9 and LIV-1

Details for Australian Patent Application No. 2004207538 (hide)

Owner Biogen Idec MA Inc.

Inventors McLachlan, Karen; Glaser, Scott; Peach, Robert J.; Rowe, Tony

Agent Cullen & Co

Pub. Number AU-A-2004207538

PCT Pub. Number WO2004/066933

Priority 60/442,535 27.01.03 US

Filing date 27 January 2004

Wipo publication date 12 August 2004

International Classifications

A61K 051/00 Preparations containing radioactive substances for use in therapy or testing

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/066933 Priority application(s): WO2004/066933

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207543-Sensitive proteasome sensor constructs and methods for their design and use

2004207536-Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents